← Leaderboards
Zhaohui Sunny Zhou
Washington State University
$2,505,372
Attributed
$2,505,372
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $295.4K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,505,372 · 2
By mechanism
R01$2,505,372 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogBiochemicalMutantPositioning AttributeRegulationEnzyme ActivityCrosslinkComplementDeamidationBinding (Molecular Function)BrainChemistryAllelesAntibodiesAutoimmunityAutoimmune DiseasesAspartic AcidAsparagineAmyloid Beta-ProteinAreaAnimalsAdductAge RelatedAlzheimer&Apos
Grant awards (10)
Protein Modification: Isoaspartic Acid$295,450
R01 · FY2015 · GM · contact PI
Protein Modification: Isoaspartic Acid$295,450
R01 · FY2014 · GM · contact PI
Protein Modification: Isoaspartic Acid$268,217
R01 · FY2013 · GM · contact PI
Protein Modification: Isoaspartic Acid$278,578
R01 · FY2012 · GM · contact PI
Mechanism and Inhibition for LuxS: A Biodefense Target$255,563
R01 · FY2008 · AI · contact PI
Mechanism and Inhibition for LuxS: A Biodefense Target$260,513
R01 · FY2007 · AI · contact PI
Mechanism and Inhibition for LuxS: A Biodefense Target$198,548
R01 · FY2006 · AI · contact PI
Mechanism and Inhibition for LuxS: A Biodefense Target$65,214
R01 · FY2006 · AI · contact PI
Mechanism and Inhibition for LuxS: A Biodefense Target$287,115
R01 · FY2005 · AI
Mechanism and Inhibition for LuxS: A Biodefense Target$300,724
R01 · FY2004 · AI